We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Boosts Impax In Aventis Patent Suit

Law360 (November 21, 2006, 12:00 AM EST) -- A federal appeals court has given generic drug maker Impax Laboratories Inc. another chance to strike down a hotly contested patent for the Lou Gehrig's disease treatment held by rival Aventis...
To view the full article, register now.